Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations

Journal of Autoimmunity

Volumn 60, Issue , 2015, Pages 51-58

  Sharma, Shruti ^a   Jin, Zhongbo ^b   Rosenzweig, Elizabeth ^a   Rao, Swapna ^a   Ko, Kichul ^a   Niewold, Timothy B ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Ancestral background; Gene expression; Interferon; Systemic lupus erythematosus

Indexed keywords

INTERFERON;

AFRICAN AMERICAN; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EUROPEAN AMERICAN; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; IMMUNOCOMPETENT CELL; MONOCYTE; NUCLEOTIDE SEQUENCE; PERSONALIZED MEDICINE; PLESIOMORPHY; PRIORITY JOURNAL; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; BIOSYNTHESIS; CAUCASIAN; CLASSIFICATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY;

AFRICAN AMERICANS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERFERONS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MONOCYTES;

EID: 84931009595     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2015.04.002     Document Type: Article

References (43)

1. Sanchez E., Rasmussen A., Riba L., Acevedo-Vasquez E., Kelly J.A., Langefeld C.D., et al. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum. 2012, 64:3687-3694.
2. Ramos P.S., Oates J.C., Kamen D.L., Williams A.H., Gaffney P.M., Kelly J.A., et al. Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry. J.Rheumatol. 2013, 40:842-849.
3. Sanchez E., Comeau M.E., Freedman B.I., Kelly J.A., Kaufman K.M., Langefeld C.D., et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum. 2011, 63:3493-3501.
4. Pothlichet J., Niewold T.B., Vitour D., Solhonne B., Crow M.K., Si-Tahar M. Aloss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. EMBO Mol. Med. 2011, 3:142-152.
5. Lodolce J.P., Kolodziej L.E., Rhee L., Kariuki S.N., Franek B.S., McGreal N.M., et al. African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. J.Immunol. 2010, 184:7001-7009.
6. Ghodke-Puranik Y., Niewold T.B. Genetics of the type I interferon pathway in systemic lupus erythematosus. Int. J. Clin. Rheumatol. 2013, 8.
7. Niewold T.B. Interferon alpha as a primary pathogenic factor in human lupus. Journal of interferon & cytokine research. Off. J. Int. Soc. Interferon Cytokine Res. 2011, 31:887-892.
8. Shrivastav M., Niewold T.B. Nucleic acid sensors type I interferon production in systemic lupus erythematosus. Front. Immunol. 2013, 4:319.
9. Niewold T.B., Hua J., Lehman T.J., Harley J.B., Crow M.K. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes. Immun. 2007, 8:492-502.
10. Kariuki S.N., Franek B.S., Kumar A.A., Arrington J., Mikolaitis R.A., Utset T.O., et al. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res. Ther. 2010, 12:R151.
11. Kim T., Kanayama Y., Negoro N., Okamura M., Takeda T., Inoue T. Serum levels of interferons in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 1987, 70:562-569.
12. Kirou K.A., Lee C., George S., Louca K., Peterson M.G., Crow M.K. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 2005, 52:1491-1503.
13. Weckerle C.E., Franek B.S., Kelly J.A., Kumabe M., Mikolaitis R.A., Green S.L., et al. Network analysis of associations between serum interferon-alpha activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2011, 63:1044-1053.
14. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J.Exp. Med. 2003, 197:711-723.
15. Kirou K.A., Lee C., George S., Louca K., Papagiannis I.G., Peterson M.G., et al. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 2004, 50:3958-3967.
16. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2610-2615.
17. Pascual V., Allantaz F., Patel P., Palucka A.K., Chaussabel D., Banchereau J. How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets. Immunol. Rev. 2008, 223:39-59.
18. Mandel M., Achiron A. Gene expression studies in systemic lupus erythematosus. Lupus 2006, 15:451-456.
19. Ronnblom L., Eloranta M.L. The interferon signature in autoimmune diseases. Curr. Opin. Rheumatol. 2013, 25:248-253.
20. Higgs B.W., Zhu W., Richman L., Fiorentino D.F., Greenberg S.A., Jallal B., et al. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients. Int. J. Rheum. Dis. 2012, 15:25-35.
21. Berry M.P., Graham C.M., McNab F.W., Xu Z., Bloch S.A., Oni T., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
22. Kawasaki M., Fujishiro M., Yamaguchi A., Nozawa K., Kaneko H., Takasaki Y., et al. Fluctuations in the gene expression of peripheral blood mononuclear cells between the active and inactive phases of systemic lupus erythematosus. Clin. Exp. Rheumatol. 2010, 28:311-317.
23. Whitney A.R., Diehn M., Popper S.J., Alizadeh A.A., Boldrick J.C., Relman D.A., et al. Individuality and variation in gene expression patterns in human blood. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1896-1901.
24. McKinney E.F., Lyons P.A., Carr E.J., Hollis J.L., Jayne D.R., Willcocks L.C., et al. ACD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat. Med. 2010, 16:586-591. 1p following 91.
25. Garaud J.C., Schickel J.N., Blaison G., Knapp A.M., Dembele D., Ruer-Laventie J., et al. Bcell signature during inactive systemic lupus is heterogeneous: toward a biological dissection of lupus. PLoS One 2011, 6:e23900.
26. Kawasaki M., Fujishiro M., Yamaguchi A., Nozawa K., Kaneko H., Takasaki Y., et al. Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus. Lupus 2011, 20:1231-1239.
27. Becker A.M., Dao K.H., Han B.K., Kornu R., Lakhanpal S., Mobley A.B., et al. SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One 2013, 8:e67003.
28. Lyons P.A., McKinney E.F., Rayner T.F., Hatton A., Woffendin H.B., Koukoulaki M., et al. Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis. Ann. Rheum. Dis. 2010, 69:1208-1213.
29. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
30. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25:1271-1277.
31. Santer D.M., Wiedeman A.E., Teal T.H., Ghosh P., Elkon K.B. Plasmacytoid dendritic cells and C1q differentially regulate inflammatory gene induction by lupus immune complexes. J.Immunol. 2012, 188:902-915.
32. van Baarsen L.G., Wijbrandts C.A., Rustenburg F., Cantaert T., van der Pouw Kraan T.C., Baeten D.L., et al. Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment. Arthritis Res. Ther. 2010, 12:R11.
33. Guiducci C., Gong M., Xu Z., Gill M., Chaussabel D., Meeker T., et al. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 2010, 465:937-941.
34. Zimmerer J.M., Lesinski G.B., Ruppert A.S., Radmacher M.D., Noble C., Kendra K., et al. Gene expression profiling reveals similarities between the invitro and invivo responses of immune effector cells to IFN-alpha. Clin. Cancer Res. 2008, 14:5900-5906.
35. Pos Z., Selleri S., Spivey T.L., Wang J.K., Liu H., Worschech A., et al. Genomic scale analysis of racial impact on response to IFN-alpha. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:803-808.
36. Hervas-Stubbs S., Perez-Gracia J.L., Rouzaut A., Sanmamed M.F., Le Bon A., Melero I. Direct effects of type I interferons on cells of the immune system. Clin. Cancer Res. 2011, 17:2619-2627.
37. Yao Y., Richman L., Higgs B.W., Morehouse C.A., de los Reyes M., Brohawn P., et al. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum. 2009, 60:1785-1796.
38. Kariuki S.N., Ghodke-Puranik Y., Dorschner J.M., Chrabot B.S., Kelly J.A., Tsao B.P., et al. Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus. Genes Immun. 2015, 16:15-23.
39. Ko K., Koldobskaya Y., Rosenzweig E., Niewold T.B. Activation of the interferon pathway is dependent upon autoantibodies in African-American SLE patients, but not in European-American SLE patients. Front. Immunol. 2013, 4:309.
40. Fernandez D., Perl A. Metabolic control of T cell activation and death in SLE. Autoimmun. Rev. 2009, 8:184-189.
41. Wu T., Xie C., Han J., Ye Y., Weiel J., Li Q., et al. Metabolic disturbances associated with systemic lupus erythematosus. PLoS One 2012, 7:e37210.
42. Lee H.T., Lin C.S., Lee C.S., Tsai C.Y., Wei Y.H. Increased 8-hydroxy-2'-deoxyguanosine in plasma and decreased mRNA expression of human 8-oxoguanine DNA glycosylase 1, antioxidant enzymes, mitochondrial biogenesis-related proteins and glycolytic enzymes in leukocytes in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 2014 Apr, 176:66-77.
43. Ko K., Franek B.S., Marion M., Kaufman K.M., Langefeld C.D., Harley J.B., et al. Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus. J.Rheumatol. 2012, 39:1238-1240.